Funding from the NIH's National Institute on Drug Abuse (NIDA) will Support Development of ENA-001, an Agnostic Respiratory Stimulant, for Community Drug Overdose and as a Medical Countermeasure

Oxidative stress drives aging and is a key factor in diseases like Alzheimer's, Age-related Macular Degeneration (AMD), cardiovascular diseases, cancer, and diabetes. It also plays a critical role in the progression of viral infections, such as avian influenza (bird flu), by exacerbating inflammation and cellular damage. Directly addressing oxidative stress and its consequences is essential to treating the underlying causes of these conditions and mitigating the severity of viral outbreaks.

Oversubscribed Seed Round Accelerates Nasdepi®'s Journey as the First Dry Powder Nasal, Heat-Stable Treatment for Anaphylaxis

Company expands sterile fill-finish services, capacity for biologics development and manufacturing, and more

New Over-the-Counter Cold Sore Treatment Cream Clevorx is Making Its Debut in the Healthcare Market, Offering Relief to Millions of Cold Sore Sufferers

ZAGENO Forms a Strategic Partnership With Hatch.Bio Labs, a Premier Biotech Incubator

Experienced pharmacy provider now bringing expert dispensing and personalized support to PACE participants

Duty Free Meds is proud to introduce a new Zepbound coupon offering to help lower patient costs associated with the weight-loss medication. These coupons can help customers spend less on weight-loss drugs and other medications.

The interview with Dr. John Barr and Jim Patton tackles medication safety and how PillSafe Technologies secures prescriptions, prevents abuse, and protects patients and doctors, leading the fight against the opioid crisis.

Celebrating a Culture of Collaboration and a Mission to Save Lives Through Data

Transaction follows a $5 million non-dilutive credit line from the same trusted partner, further reinforcing Telomir's financial strength and growth potential.

Dry Powder Epinephrine Product Demonstrates Reliable and Consistent Delivery in Real-World Dosing Situations with a Heat-Stable Formulation

Individuals with a high polygenic risk are likely to derive the most benefit from lifestyle change and/or therapeutic intervention

Strong Safety Profile Validated Across Studies, Setting the Stage for Clinical Trials in Neuropathic Pain

Building on preclinical success demonstrating age reversal, longevity, and increased healthspan, Telomir-1 appears to address insulin resistance at its root, achieving reversal to near pre-diabetic levels

New Members Strengthen Board of Directors

Backed by a Strong Balance Sheet, MIRA Accelerates Toward Becoming a Clinical-Stage Company and Advancing Breakthroughs in Pain and Depression Treatment

CaaMTech’s New Clinical Trial Design Solves the Emergent Functional Unblinding Problems Plaguing Psychedelic Medicine Developers

The New Patent Covers ENA-001 Methods of Treating Respiratory Depression Caused by Propofol, a Widely Used, Centrally Acting Anesthetic

McNamara’s extensive experience in scaling imaging and eClinical companies through organic growth and acquisition strategies brings a wealth of expertise to accelerate Yunu’s life sciences business. 

Nemysis Limited is pleased to announce the successful acquisition of TFarma SRL ("TFarma") by its wholly-owned subsidiary, Enteralia Bioscience SRL ("Enteralia").

Innovation grants from the biotechnology creators of sustained acoustic medicine (sam®) will advance recipients’ careers in biomedical engineering and sports medicine.